- Home
- GALT vs MAPS Comparison
GALT vs MAPS Comparison
Compare GALT & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- MAPS
- Stock Information
- Founded
- GALT 2000
- MAPS 2008
- Country
- GALT United States
- MAPS United States
- Employees
- GALT N/A
- MAPS N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- MAPS Computer Software: Prepackaged Software
- Sector
- GALT Health Care
- MAPS Technology
- Exchange
- GALT Nasdaq
- MAPS Nasdaq
- Market Cap
- GALT 147.8M
- MAPS 119.8M
- IPO Year
- GALT N/A
- MAPS N/A
- Fundamental
- Price
- GALT $2.12
- MAPS $1.22
- Analyst Decision
- GALT Strong Buy
- MAPS Buy
- Analyst Count
- GALT 1
- MAPS 2
- Target Price
- GALT $11.00
- MAPS $2.61
- AVG Volume (30 Days)
- GALT 549.5K
- MAPS 1.0M
- Earning Date
- GALT 11-13-2024
- MAPS 11-12-2024
- Dividend Yield
- GALT N/A
- MAPS N/A
- EPS Growth
- GALT N/A
- MAPS N/A
- EPS
- GALT N/A
- MAPS N/A
- Revenue
- GALT N/A
- MAPS $183,311,000.00
- Revenue This Year
- GALT N/A
- MAPS N/A
- Revenue Next Year
- GALT N/A
- MAPS $9.09
- P/E Ratio
- GALT N/A
- MAPS N/A
- Revenue Growth
- GALT N/A
- MAPS N/A
- 52 Week Low
- GALT $1.56
- MAPS $0.70
- 52 Week High
- GALT $4.27
- MAPS $1.49
- Technical
- Relative Strength Index (RSI)
- GALT 39.78
- MAPS 52.06
- Support Level
- GALT $1.80
- MAPS $1.07
- Resistance Level
- GALT $2.36
- MAPS $1.49
- Average True Range (ATR)
- GALT 0.23
- MAPS 0.13
- MACD
- GALT -0.03
- MAPS -0.03
- Stochastic Oscillator
- GALT 26.89
- MAPS 35.71
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.